Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient

Nephrology Dialysis Transplantation

Volumn 16, Issue 12, 2001, Pages 2420-2422

  Shan, Yan Shen ^a   Lee, Po Chang ^a,b   Wang, Jen Ren ^a   Tsai, Huey Pin ^a   Sung, Chunne Ming ^a   Jin, Ying Tai ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Fibrosing cholestatic hepatitis; Intravenous immunoglobulin; Parvovirus B19; Polymerase chain reaction; Renal transplantation

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; VIRUS DNA;

ADOLESCENT; ANAMNESIS; ARTICLE; AUTOPSY; CADAVER DONOR; CASE REPORT; CAUSE OF DEATH; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER FAILURE; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; SEROLOGY; VIRUS INFECTION;

EID: 0035210748     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.12.2420     Document Type: Article

References (14)

1. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice
2. High level expression of hepatitis B virus (HBV) antigens in fibrosing cholestatic hepatitis. Evidence that HBV may be cytopathic in liver grafts
3. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis
4. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation
5. Parvovirus B19 in human disease
6. Liver dysfunction caused by parvovirus B19
7. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature
8. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia
9. Parvovirus B19-related hepatitis in an immunosuppressed kidney transplant
10. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients
11. Parvovirus B19 infection-related complications in renal transplant recipients. Treatment with intravenous immunoglobulin
12. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus typeI (HIV-I): A treatable cause of anemia in AIDS
13. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during Lamivudine therapy in patients with chronic hepatitis B
14. Nucloside analogue therapy in fibrosing cholestatic hepatitis-a case report in an HBsAg positive renal transplant recipient